Skip to content
  • Saturday, 15 August 2026
  • 12:28 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • ADA Conference Marked by Landmark GLP-1 Trial Results Amidst Unprecedented Scientific Dissent and Police Intervention
Laboratory Automation & Robotics

ADA Conference Marked by Landmark GLP-1 Trial Results Amidst Unprecedented Scientific Dissent and Police Intervention

Lana Keisha Jul 20, 2026 0

The annual national conference of the American Diabetes Association (ADA) this week served as a dual stage: a vibrant forum…

Read More
Environmental & Analytical Chemistry

The Scientific Party Trick Results from Mini Blasts Ignited by Sparks, Experiments Suggest

Abdurrohim Arsyad Jul 7, 2026 0

At the recent annual meeting of the Electrostatics Society of America, held in Cocoa Beach, Florida, an unexpected demonstration captivated…

Read More
Pharmaceutical R&D

Sanofi’s Nexviazyme Demonstrates Promising Results in Infants with Infantile-Onset Pompe Disease, Paving Way for Potential Label Expansion

Teuku Ryan Jul 1, 2026 0

Sanofi’s groundbreaking treatment for Pompe disease, Nexviazyme (avalglucosidase alfa), has achieved a significant milestone with the successful completion of the…

Read More
Laboratory Automation & Robotics

ADA Conference Concludes with Groundbreaking GLP-1 Trial Results Amidst Unprecedented Protests Over Science Policy

Lana Keisha Jun 14, 2026 0

The annual scientific sessions of the American Diabetes Association (ADA) this week served as a pivotal platform for unveiling cutting-edge…

Read More
Environmental & Analytical Chemistry

Studies show AI agents struggle to use the results of experiments to revise their ideas

Abdurrohim Arsyad May 27, 2026 0

New research published in the journal Nature Human Behaviour has revealed a significant limitation in the reasoning capabilities of advanced…

Read More
Pharmaceutical R&D

Tirzepatide Confirmed as Best-in-Class Obesity Therapy Following Landmark SURMOUNT-MAINTAIN Trial Results

Teuku Ryan May 17, 2026 0

Findings from the pivotal Phase III SURMOUNT-MAINTAIN trial, presented at the 33rd European Congress on Obesity (ECO) in Istanbul, Türkiye,…

Read More
Pharmaceutical R&D

Novel Combination Therapy CagriSema Demonstrates Promising Results in Obesity Management with Preserved Muscle Strength

Teuku Ryan May 13, 2026 0

On 12 May 2026, at the 33rd European Congress on Obesity (ECO) in Istanbul, Türkiye, groundbreaking findings from the Phase…

Read More
Error woes that plague quantum computers may be solved by using the math of topologyScience News: Empowering Public Understanding of Science, Medicine, and Technology Since 1921Unlocking the Mechanism of Lecanemab: VIB-KU Leuven Researchers Identify Fc Fragment as Essential for Microglial Activation in Alzheimer’s TreatmentThe New York Times spotlighted MEDVi. The FDA had already warned the self-proclaimed ‘fastest growing company in history.’
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ